Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients

Neuroscience

Volumn 122, Issue 2, 2003, Pages 305-315

  Ji, Y ^a   Gong, Y ^a   Gan, W ^a   Beach, T ^b   Holtzman, D M ^c   Wisniewski, T ^a,d  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SUN HEALTH RESEARCH INSTITUTE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; Apolipoprotein E; Dendrite spine; Dentate gyrus; Neuronal plasticity; Transgenic mice

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITIC SPINE; DENTATE GYRUS; GENE CONTROL; GRANULE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRANSGENIC MOUSE; WILD TYPE;

EID: 0242403213     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2003.08.007     Document Type: Article

References (69)

1. Alberts M.J., Graffagnino C., McCleeny C., DeLong D., Strittmatter W., Saunders A., Roses A.D. ApoE genotype and survival from intracerebral haemorrhage. Lancet. 346:1995;575.
2. Bales K.R., Verina T., Dodel R.C., Du Y.S., Altstiel L., Bender M., Hyslop P., Johnstone E.M., Little S.P., Cummins D.J., Piccardo P., Ghetti B., Paul S.M. Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition. Nat Genet. 17:1997;263-264.
3. Bellosta S., Nathan B.P., Orth M., Dong L.M., Mahley R.W., Pitas R.E. Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem. 270:1995;27063-27071.
4. Bonhoeffer T., Yeste R. Spine motility phenomenology, mechanisms and function . Neuron. 35:2002;1019-1027.
5. Boyles J.K., Zoellner C.D., Anderson L.J., Kosik L.M., Pitas R.E., Weisgraber K.H., Hui D.Y., Mahley R.W., Gebicke-Haerter P.J., Ignatias M.J., Shooter E.M. A role for apolipoprotein E, apoprotein A-1, low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the sciatic nerve. J Clin Invest. 83:1989;1015-1031.
6. Buttini M., Akeefe H., Lin C., Mahley R.W., Pitas R.E., Wyss-Coray T., Mucke L. Dominant negative effects of apolipoprotein E4 revealed in transgenic models of neurodegenerative disease. Neuroscience. 97:2000;207-210.
7. Caselli R.J., Osborne D., Reiman E.M., Hentz J.G., Barbieri C.J., Saunders A.M., Hardy J., Graff-Radford N.R., Hall G.R., Alexander G.E. Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes a replication study . J Neurol Sci. 189:2001;93-98.
8. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
9. De Chaves E.I., Rusinol A.E., Vance D.E., Campenot R.B., Vance J.E. Role of lipoproteins in the delivery of lipids to axons during axonal regeneration. J Biol Chem. 272:1997;30766-30773.
10. Deary I.J., Whiteman M.C., Pattie A., Starr J.M., Hayward C., Wright A.F., Carothers A., Whalley L.J. Cognitive change and the APOE epsilon 4 allele. Nature. 418:2002;932.
11. DeKosky S.T., Scheff S.W. Synapse loss in frontal cortex biopsies in Alzheimer's disease correlation with cognitive severity . Ann Neurol. 27:1990;457-464.
12. Dik M.G., Jonker C., Bouter L.M., Geerlings M.I., van Kamp G.J., Deeg D.J. APOE-epsilon 4 is associated with memory decline in congnitively impaired elderly. Neurology. 54:2000;1492-1497.
13. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A. Effects of age, sex and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease a meta-analysis: APOE and Alzheimer disease meta analysis consortium . JAMA. 278:1997;1349-1356.
14. Flory J.D., Manuck S.B., Ferrell R.E., Ryan C.M., Muldoon M.F. Memory performance and the apolipoprotein E polymorphism in a community sample of middle-aged adults. Am J Med Genet. 96:2000;707-711.
15. Gan W.B., Grutzendler J., Wong W.T., Wong R.O., Lichtman J.W. Multicolor "DiOlistic" labeling of the nervous system using lipophilic dye combinations. Neuron. 27:2000;219-225.
16. Gearing M., Mirra S.S., Hedreen J.C., Sumi S.M., Hansen L.A., Heyman A. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease . Neurology. 45:(Pt 1):1995;461-466.
17. Grutzendler J., Tsai J., Gan W.B. Rapid labeling of neuronal populations by ballistic delivery of fluorescent dyes. Methods. 30:2003;79-85.
18. Handelmann G.E., Boyles J.K., Weisgraber K.H., Mahley R.W., Pitas R.E. Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro. J Lipid Res. 33:1992;1677-1688.
19. Harris K.M., Kater S.B. Dendritic spines cellular specializations imparting both stability and flexibility to synaptic function . Ann Rev Neurosci. 17:1994;341-371.
20. Hartman R.E., Wozniak D.F., Nardi A., Olney J.W., Sartorius L., Holtzman D.M. Behaviioral phenotyping of GFAP-apoE3 and apoE4 transgenic mice apoE4 mice show profound working memory impairments in the absence of Alzheimer's like neuropathology . Exp Neurol. 179:2001;326-344.
21. Holtzman D.M., Bales K.R., Tenkova T., Fagan A.M., Parsadanian M., Sartorius L.J., Mackey B., Olney J., McKeel D., Wozniak D., Paul S.M. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA. 97:2000;2892-2897.
22. Holtzman D.M., Bales K.R., Wu S., Bhat P., Parsadanian M., Fagan A.M., Chang L.K., Sun Y., Paul S.M. Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease. J Clin Invest. 103:1999;R15-R21.
23. Holtzman D.M., Fagan A.M., Mackey B., Tenkova T., Sartorius L., Paul S.M., Bales K.R., Hsiao Ashe K., Irizarry M.C., Hyman B.T. Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model. Ann Neurol. 47:2000;739-747.
24. Honer W.G., Dickson D.W., Gleeson J., Davies P. Regional synaptic pathology in Alzheimer's disease. Neurobiol Aging. 13:1992;375-382.
25. Horsburgh K., McCulloch J., Nilsen M., Roses A.D., Nicoll J.A. Increased neuronal damage and apoE immunoreactivity in human apolipoprotein E, E4 isoform-specific, transgenic mice after global cerebral ischemia. Eur J Neurosci. 12:2000;4309-4317.
26. Hyman B.T., Gomez-Isla T., Irizarry M.C. Stereology a practical primer for neuropathology . J Neuropathol Exp Neurol. 57:1998;305-310.
27. Jang M., Maestre G., Tsai W., Jui X., Feng L., Chung W., Churi M., Schofield P., Stern Y., Tycko B., Mayeux R. Effects of age, ethnicity and head injury on the association between apoE genotypes and Alzheimer's disease. Anna NY Acad Sci. 802:1996;6-15.
28. Laws S.M., Hone E., Gandy S., Martins R.N. Expanding the association between the APOE gene and the risk of Alzheimer's disease possible roles for APOE promoter polymorphisms and alterations in APOE transcription . J Neurochem. 84:2003;1215-1236.
29. Lendon C.L., Han B.H., Salimi K., Fagan A.M., Behrens M.I., Muller M.C., Holtzman D.M. No effect of apolipoprotein E on neuronal cell death due to excitotoxic and apoptotic agents in vitro and neonatal hypoxia ischaemia in vivo. Eur J Neurosci. 12:2000;2235-2242.
30. Lippa C.F., Hamos J.E., Pulaski-Salo D., DeGennaro L.J., Drachman D. Alzheimer's disease and aging effects on perforant pathway perikarya and synapses . Neurobiol Aging. 13:1992;405-411.
31. Ma J., Yee A., Brewer H.B. Jr, Das S., Potter H. Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature. 372:1994;92-94.
32. Mahley R.W. Apolipoprotein E cholesterol transport protein with expanding role in cell biology . Science. 240:1988;622-630.
33. Mahley R.W., Nathan B.P., Pitas R.E. Apolipoprotein E structure, function, and possible roles in Alzheimer's disease . Ann NY Acad Sci. 777:1996;139-145.
34. Masliah E., Ellisman M., Carragher B., Mallory M., Young S., Hansen L., DeTeresa R., Terry R.D. Three-dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer disease. J Neuropathol Exp Neurol. 51:1992;404-414.
35. Masliah E., Samuel W., Veinbergs I., Mallory M., Mante M., Saitoh T. Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain Res. 751:1997;307-314.
36. Masliah E., Terry R.D., Alford M., DeTeresa R., Hansen L.A. Cortical and subcortical patterns of synaptophysin like immunoreactivity in Alzheimer's disease. Am J Pathol. 138:1991;235-246.
37. Nathan B.P., Bellosta S., Sanan D.A., Weisgraber K.H., Mahley R.W., Pitas R.E. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 264:1994;850-852.
38. Nathan B.P., Chang K.C., Bellosta S., Brisch E., Ge N., Mahley R.W., Pitas R.E. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization. J Biol Chem. 270:1995;19791-19799.
39. Nicoll J.A., Roberts G.W., Graham D.I. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury. Nat Med. 1:1995;135-137.
40. Permanne B., Perez C., Soto C., Frangione B., Wisniewski T. Detection of apolipoprotein E dimeric soluble amyloid β complexes in Alzheimer's disease brain supernatants. Biochem Biophys Res Commun. 240:1997;715-720.
41. Poirer J., Minnich A., Davignon J. Apolipoprotein E, synaptic plasticity and Alzheimer's disease. Ann Med. 27:1995;663-670.
42. Postuma R.B., Martins R.N., Cappai R., Beyreuther K., Masters C.L., Strickland D.K., Mok S.S., Small D.H. Effects of the amyloid protein precursor of Alzheimer's disease and other ligands of the LDL receptor related protein on neurite outgrowth from sympathetic neurons in culture. FEBS Lett. 428:1998;13-16.
43. Raber J., Wong D., Gui-Qui Y., Buttini M., Mahley R.W., Pitas R.E., Mucke L. Apolipoprotein E and cognitive performance. Nature. 404:2000;352-353.
44. Rebeck G.W., Reiter J.S., Strickland D.K., Hyman B.T. Apolipoprotein E in sporadic Alzheimer's disease allelic variation and receptor interactions . Neuron. 11:1993;575-580.
45. Sanan D.A., Weisgraber K.H., Russell S.J., Mahley R.W., Huang D., Saunders A., Schmechel D., Wisniewski T., Frangione B., Roses A.D., Strittmatter W.J. Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils isoform apoE4 associates more efficiently than apoE3 . J Clin Invest. 94:1994;860-869.
46. Scheff S.W., Sparks D.L., Price D.A. Quantitative assessment of synaptic density in the outer molecular layer of the hippocampal dentate gyrus in Alzheimer's disease. Dementia. 7:1996;226-232.
47. Schmechel D., Saunders A., Strittmatter W., Crain B.J., Hulette C., Joo S.H., Pericak-Vance M., Goldgaber D., Roses A. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Natl Acad Sci USA. 90:1993;9649-9653.
48. Sigurdsson E.M., Scholtzova H., Mehta P., Frangione B., Wisniewski T. Immunization with a nontoxic/nonfibrillar amyloid-β homologous peptide reduces Alzheimer's disease associated pathology in transgenic mice. Am J Pathol. 159:2001;439-447.
49. Soto C., Golabek A.A., Wisniewski T., Castaño E.M. Alzheimer's soluble β-amyloid is conformationally modified by apolipoproteins in vitro. Neuroreport. 7:1996;721-725.
50. Sun Y., Wu S., Bu G., Onifade M.K., Patel S.N., LaDu M.J., Fagan A.M., Holtzman D.M. Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins . J Neurosci. 18:1998;3261-3272.
51. Sze C.I., Troncoso J.C., Kawas C.H., Mouton P., Price D.L., Martin L.J. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J Neuropathol Exp Neurol. 56:1997;933-944.
52. Tardiff B., Newman M., Saunders A., Strittmatter W., Blumenthal J.A., White W.D., Croughwell N.D., Davis R.D., Roses A.D., Reves J.G. Preliminary report of a genetic basis for cognitive decline after cardiac operations the Neurological Outcome Research Group of the Duke Heart Center . Ann Thorac Surg. 64:1997;715-720.
53. Teasdale G.M., Nicoll J.A.R., Murray G., Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet. 350:1997;1069-1071.
54. Terry R.D. Neuropathological changes in Alzheimer disease. Prog Brain Res. 101:1994;383-390.
55. Terry R.D. The cytoskeleton in Alzheimer's disease. J Neural Transm. 53:1998;141-145.
56. Terry R.D., Masliah E., Salmon D.P., Butters N., DeTeresa R., Hill R., Hansen L.A., Katzman R. Physical basis of cognitive alterations in Alzheimer's disease synapse loss is the major correlate of cognitive impairment . Ann Neurol. 30:1991;572-580.
57. Teter B., Xu P.T., Gilbert J.R., Roses A.D., Galasko D., Cole G.M. Human apolipoprotein E isoform-specific differences in neuronal sprouting in organotypic hippocampal slice culture. J Neurochem. 73:1999;2613-2616.
58. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging. 18:1997;S1-S2.
59. van Rossum D. Cytoskeletal dynamics in dendritic spines direct modulation by glutamate receptors? Trends Neurosci. 22:1999;290-295.
60. Wegiel J., Wisniewski H.M., Kuchna I., Tarnawski M., Badmajew E., Popovitch E., Kulczycki J., Dowjat W.K., Wisniewski T. Cell-type specific enhancement of amyloid-β deposition in a novel presenilin-1 mutation (P117L). J Neuropathol Exp Neurol. 57:1998;831-838.
61. Wegiel J., Wisniewski T., Reisberg B., Silverman W. Alzheimer dementia neuropathology. Emery O.B., Oxman T.E. Dementia; presentations, differential diagnosis and nosology. 2003;89-120 Johns Hopkins University Press, Baltimore.
62. Wenham P.R., Price W.H., Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 337:1991;1158-1159.
63. White F., Nicoll J.A.R., Roses A., Horsburgh K. Impaired neuronal plasticity in transgenic mice expressing human apolipoprotein E4 compared to E3 in a model of entorhinal cortex lesion. Neurobiol Dis. 8:2001;611-625.
64. Wisniewski T., Castaño E.M., Golabek A.A., Vogel T., Frangione B. Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am J Pathol. 145:1994;1030-1035.
65. Wisniewski T., Frangione B. Apolipoprotein E a pathological chaperone protein in patients with cerebral and systemic amyloid . Neurosci Lett. 135:1992;235-238.
66. Wisniewski T., Frangione B. Apolipoprotein E, amyloidosis and Alzheimer's disease. Dementia. 10:1996;171-183.
67. Wisniewski T., Golabek A.A., Kida E., Wisniewski K.E., Frangione B. Conformational mimicry in Alzheimer's disease; role of apolipoproteins in amyloidogenesis. Am J Pathol. 147:1995;238-244.
68. Yamagata K., Urakami K., Ikeda K., Ji Y., Adachi Y., Arai H., Sasaki H., Sato K., Nakashima K. High expression of apolipoprotein E mRNA in the brains with sporadic Alzheimer's disease. Dement Geriatr Cogn Disord. 12:2001;57-62.
69. Zarrow C., Victoroff J. Increased apolipoprotein E mRNA in the hippocampus in Alzheimer disease and in rats after entorhinal cortex lesioning. Exp Neurol. 149:1998;79-86.